Latest Manufacturing News

Argent BioPharma reports significant operational savings through manufacturing outsourcing, encouraging Phase IIb results for CimetrA®, and key regulatory approvals for cannabinoid therapies in Germany.

Australian Rare Earths Limited (ASX: AR3) has successfully raised $3.6 million through a fully subscribed rights issue, backed strongly by existing shareholders and directors. The capital injection positions AR3 to advance uranium exploration and rare earth development amid favorable geopolitical shifts.

Sparc Technologies has progressed to Stage 2 of its Sparc Hydrogen joint venture with pilot plant commissioning slated for mid-2025, while also securing its first patent for photocatalytic water splitting technology in Morocco. Concurrently, its graphene-based additive ecosparc® demonstrates promising field trial results, underpinning commercial momentum.

Patrys Limited advances its PAT-DX3 therapy development for inflammatory diseases while navigating cash flow challenges and pursuing partnerships to sustain operations.

Farm Pride Foods reports a 15% rise in production following successful repopulation of Avian Influenza-impacted farms, alongside improved cash flow and strategic loan conversion.

Blue Star Helium has reported strong flow test results from its Bubba State 3 well in Lincoln County, Colorado, confirming helium concentrations around 2.01% and robust production rates that support further development.

RLF AgTech has secured major national distribution agreements in Australia, launched a comprehensive retail rollout, and restructured its manufacturing arm, LiquaForce, to drive growth and operational efficiency. The company also reported strong financial performance and expanded its footprint across Asia.

RooLife Group Ltd (RLG) has inked exclusive decade-long agreements with three Chinese companies to market and distribute branded solar energy systems worldwide, marking a strategic expansion into the renewable energy sector.

Constellation Technologies Limited reports sustained sales growth and positive cash flow in Q3 2025, driven by its Callisto Food Safety & Compliance system and strategic market expansion.

Beonic Limited reported a 6.5% increase in annual recurring revenue to $17.8 million and a significant gross margin improvement to 75.5%, driven by new global contracts and disciplined cost management. The company targets cash flow breakeven in Q4 FY25 and an EBITDA margin of up to 15%.

Quickstep Holdings reported a $5.8 million net operating cash outflow in Q3 FY25 but bolstered liquidity by securing $6.6 million in customer advances and implementing cost controls.

INOVIQ Limited reports significant progress in its exosome-based cancer diagnostics and therapeutics, including expanded customer adoption, advanced AI screening tests, and strategic partnerships with leading research centres.